Certain Toxicities Could Be Correlated With mTOR Efficacy in Metastatic RCC

A study has shown a link between metabolic toxicities and the efficacy of mTOR inhibitors for the treatment of metastatic renal cell carcinoma.

Source: CancerNetwork - January 22, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news